By-health Co Ltd
SZSE:300146
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
By-health Co Ltd
By-health Co Ltd
Cash & Cash Equivalents
By-health Co Ltd
Cash & Cash Equivalents Peer Comparison
1044
603605
300957
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
By-health Co Ltd
SZSE:300146
|
Cash & Cash Equivalents
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Cash & Cash Equivalents
¥18.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
S
|
Shanghai Flyco Electrical Appliance Co Ltd
SSE:603868
|
Cash & Cash Equivalents
¥524.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Proya Cosmetics Co Ltd
SSE:603605
|
Cash & Cash Equivalents
¥3.7B
|
CAGR 3-Years
40%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Cash & Cash Equivalents
¥2.1B
|
CAGR 3-Years
40%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Cash & Cash Equivalents
¥2.5B
|
CAGR 3-Years
90%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is By-health Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.3B
CNY
Based on the financial report for Dec 31, 2023, By-health Co Ltd's Cash & Cash Equivalents amounts to 3.3B CNY.
What is By-health Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
13%
Over the last year, the Cash & Cash Equivalents growth was 12%. The average annual Cash & Cash Equivalents growth rates for By-health Co Ltd have been 22% over the past three years , 13% over the past five years .
You don't have any saved screeners yet
